Thats about a 10% increase from the previous year
While they were initially created to control diabetes, they have been proven to be effective tools for weight loss
Certain factors may increase susceptibility to burping and related gastrointestinal symptoms, including: Rapid dose escalation (not following the recommended titration schedule) Concurrent use of other medications affecting gut motility (such as opioids or anticholinergics) Pre-existing gastrointestinal conditions such as gastroparesis or gastroesophageal reflux disease (GERD) Dietary habits that promote gas production Gastrointestinal adverse effects, including burping, are generally more common and pronounced at higher doses, which explains the higher rates observed with Wegovy compared to Ozempic
We recognise how important this moment is for the millions of people who live with excess weight or obesity and known heart disease, and we will continue to advance options that put their needs first
Potential drug interactions, especially those that have a narrow therapeutic index or require close monitoring, such as oral anticoagulants, antiplatelet agents, antihypertensive medications, and other antidiabetic medications (1,3)
The overlap with starting semaglutide doses may even cause slightly lower blood glucose than usual
